换一批Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma.
第一作者：
Andrew,Grigg
第一单位：
Department of Clinical Haematology and Oncology, Royal Melbourne Hospital, Melbourne, Australia. andrew.grigg@mh.org.au
作者：
医学主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);澳大利亚(Australia);综合疗法(Combined Modality Therapy);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);欧洲(Europe);女(雌)性(Female);非格司亭(Filgrastim);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);男(雄)性(Male);中年人(Middle Aged);中性粒细胞减少(Neutropenia);疼痛(Pain);聚乙烯二醇类(Polyethylene Glycols);泼尼松(Prednisone);重组蛋白质类(Recombinant Proteins);安全(Safety);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.1080/1042819031000103953
PMID
14565651
发布时间
2022-03-11
- 浏览135
Leukemia & lymphoma
1503-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
